Austin C. Speier

Chief Strategy Officer @ Click Therapeutics arrow icon

About Austin C. Speier

Austin C. Speier is the Chief Strategy Officer with a background in emerging technologies and neurobiology research.

Known information

Austin C. Speier serves as the Chief Strategy Officer. Previously, he worked as Vice President of Emerging Technologies at Precision for Medicine, where he advised on the design and execution of development and go-to-market strategies for complex or first-in-class products. Speier collaborated closely with early-stage and venture-backed clients to address critical scientific, clinical, regulatory, and reimbursement issues. His research experience includes work at the Brigham & Women’s Hospital Center for Neurodegeneration and Disease, focusing on Alzheimer’s Disease. He holds an A.B. cum laude in Biology from Harvard College and completed the interdisciplinary Honors Neurobiology program at Harvard, receiving a certificate in Mind, Brain, and Behavior Studies.

About Click Therapeutics

Click Therapeutics develops and commercializes software as prescription medical treatments, focusing on cognitive and neurobehavioral mechanisms to address unmet medical needs. Headquartered in New York, the company collaborates with major healthcare firms and has received significant funding and recognition for its innovative digital therapeutics.

report flag Report inaccurate information

People similar to Austin C. Speier

Han Chiu

Chief Technology Officer @ Click Therapeutics

Han Chiu is the Chief Technology Officer at Syneos Health with expertise in developing prescription digital therapeutics and conducting decentralized clinical trials.

Shaheen Lakhan

Chief Medical Officer @ Click Therapeutics

Shaheen Lakhan is the Chief Medical Officer with an MD, PhD, and is a Fellow of the American Academy of Neurology. He has a background in clinical and academic medicine and has published research on digital therapeutics in mental health.

Austin Speier

Chief Strategy Officer @ Click Therapeutics

Austin Speier is the Chief Strategy Officer with a background in emerging technologies and neurodegeneration research.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free